 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 1325
H.P. 919 House of  Representatives,  April 4, 2017
An Act  Regarding Opioids and  Palliative  Care
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative BROOKS  of Lewiston.

 
 Page 1 - 128LR2020(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  32 MRSA §2210, sub -§2, ¶A, as enacted by PL 2015, c. 488, §13, is 2 
amended to read:  3 
A.  When prescribing opioid medication to a patient for:  4 
(1)  Pain associated with active and aftercar e cancer treatment;  5 
(2)  Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph 6 
A, in conjunction with a serious illness, as defined in Title 22, section 1726, 7 
subsection 1, paragraph B;  8 
(2-A) Palliative care, as defined in Title 22 , section 1726, subsection 1, paragraph 9 
A, under a management plan that is submitted by the individual licensed under 10 
this chapter and approved by the Department of Health and Human Services and 11 
that documents the need for ongoing treatment of the patient that exceeds the 12 
limits under subsection 1;  13 
(3)  End -of-life and hospice care;  14 
(4)  Medication -assisted treatment for substance use disorder; or  15 
(5)  Other circumstances determined in rule by the Department of Health and 16 
Human Services pursuant to Title 22 , section 7254, subsection 2; and  17 
Sec. 2.  32 MRSA §2600 -C, sub -§2, ¶A, as enacted by PL 2015, c. 488, §17, is 18 
amended to read:  19 
A.  When prescribing opioid medication to a patient for:  20 
(1)  Pain associated with active and aftercare cancer treatment;  21 
(2)  P alliative care, as defined in Title 22, section 1726, subsection 1, paragraph 22 
A, in conjunction with a serious illness, as defined in Title 22, section 1726, 23 
subsection 1, paragraph B;  24 
(2-A) Palliative care, as defined in Title 22, section 1726, subsection  1, paragraph 25 
A, under a management plan that is submitted by the individual licensed under 26 
this chapter and approved by the Department of Health and Human Services and 27 
that documents the need for ongoing treatment of the patient that exceeds the 28 
limits un der subsection 1;  29 
(3)  End -of-life and hospice care;  30 
(4)  Medication -assisted treatment for substance use disorder; or  31 
(5)  Other circumstances determined in rule by the Department of Health and 32 
Human Services pursuant to Title 22, section 7254, subsection  2; and  33 
Sec. 3.  32 MRSA §3300 -F, sub -§2, ¶A, as enacted by PL 2015, c. 488, §20, is 34 
amended to read:  35 
A.  When prescribing opioid medication to a patient for:  36 
(1)  Pain associated with active and aftercare cancer treatment;  37 
 
 Page 2 - 128LR2020(01) -1 
 (2)  Palliative care, as defined  in Title 22, section 1726, subsection 1, paragraph 1 
A, in conjunction with a serious illness, as defined in Title 22, section 1726, 2 
subsection 1, paragraph B;  3 
(2-A) Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph 4 
A, under a m anagement plan that is submitted by the individual licensed under 5 
this chapter and approved by the Department of Health and Human Services and 6 
that documents the need for ongoing treatment of the patient that exceeds the 7 
limits under subsection 1;  8 
(3)  End -of-life and hospice care;  9 
(4)  Medication -assisted treatment for substance use disorder; or  10 
(5)  Other circumstances determined in rule by the Department of Health and 11 
Human Services pursuant to Title 22, section 7254, subsection 2; and  12 
Sec. 4.  32 MRSA § 3657, sub -§2, ¶A, as enacted by PL 2015, c. 488, §23, is 13 
amended to read:  14 
A.  When prescribing opioid medication to a patient for:  15 
(1)  Pain associated with active and aftercare cancer treatment;  16 
(2)  Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph 17 
A, in conjunction with a serious illness, as defined in Title 22, section 1726, 18 
subsection 1, paragraph B;  19 
(2-A) Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph 20 
A, under a management plan that is submi tted by the individual licensed under 21 
this chapter and approved by the Department of Health and Human Services and 22 
that documents the need for ongoing treatment of the patient that exceeds the 23 
limits under subsection 1;  24 
(3)  End -of-life and hospice care;  25 
(4)  Medication -assisted treatment for substance use disorder; or  26 
(5)  Other circumstances determined in rule by the Department of Health and 27 
Human Services pursuant to Title 22, section 7254, subsection 2; and  28 
Sec. 5.  32 MRSA §18308, sub -§2, ¶A, as enact ed by PL 2015, c. 488, §32, is 29 
amended to read:  30 
A.  When prescribing opioid medication to a patient for:  31 
(1)  Pain associated with active and aftercare cancer treatment;  32 
(2)  Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph 33 
A, in conjunction with a serious illness, as defined in Title 22, section 1726, 34 
subsection 1, paragraph B;  35 
(2-A) Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph 36 
A, under a management plan that is submitted by the individual lic ensed under 37 
this chapter and approved by the Department of Health and Human Services and 38 
 
 Page 3 - 128LR2020(01) -1 
 that documents the need for ongoing treatment of the patient that exceeds the 1 
limits under subsection 1;  2 
(3)  End -of-life and hospice care;  3 
(4)  Medication -assisted t reatment for substance use disorder; or  4 
(5)  Other circumstances determined in rule by the Department of Health and 5 
Human Services pursuant to Title 22, section 7254, subsection 2; and  6 
SUMMARY  7 
This bill allows an exemption from the limits on opioid medicat ion prescribing for a 8 
patient receiving palliative care under a management plan that is submitted by a licensed 9 
medical professional caring for the patient and approved by the Department of Health and 10 
Human Services and that documents the need for ongoing treatment of the patient that 11 
exceeds the limits on opioid medication prescribing.  12 
 
